Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 5/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | LPL | P06858 | 1/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12786219 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MAPK1TDP1TSHRHSD17B10 | |
| SCHEMBL20852371 | 0.91 | LPL (0.48) | LPLLIPGCHRNA7L3MBTL1CYP2D6 | |
| SCHEMBL11881823 | 0.88 | CYP3A4 (0.50) | ALDH1A1MAPK1TDP1TSHRHSD17B10 | |
| SCHEMBL19281434 | 0.88 | CYP3A4 (0.50) | ALDH1A1MAPK1TDP1TSHRHSD17B10 | |
| SCHEMBL13278248 | 0.86 | ALDH1A1 (0.63) | ALDH1A1MAPK1TDP1TSHRHSD17B10 | |
| SCHEMBL13278246 | 0.86 | ALDH1A1 (0.63) | ALDH1A1MAPK1TDP1TSHRHSD17B10 | |
| SCHEMBL16100133 | 0.86 | HTR2A (0.51) | ALDH1A1HSD17B10PPARAPPARGLPL | |
| SCHEMBL31644237 | 0.86 | HTR2A (0.51) | ALDH1A1HSD17B10PPARAPPARGLPL | |
| SCHEMBL1788376 | 0.84 | HTR2A (0.54) | ALDH1A1HSD17B10MAPTMEN1KMT2A | |
| SCHEMBL6278102 | 0.84 | HTR2A (0.54) | ALDH1A1HSD17B10MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116327427-A | In situ adjustable artificial lens | 爱尔康公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-113677378-B | In situ adjustable artificial lens | 爱尔康公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-113677378-A | In situ tunable intraocular lenses | 爱尔康公司 | 2021-11-19 | — | — | CN | disclosed |
| EP-2983659-B1 | DRUG DELIVERY POLYMER AND USES THEREOF | MASSACHUSETTS INST TECHNOLOGY (US) | 2019-11-20 | — | — | EP | disclosed |
| EP-3497446-A1 | METHOD AND COMPOSITION FOR DETECTION OF PEPTIDE CYCLIZATION USING PROTEIN TAGS | H. Hoffnabb-La Roche Ag (CH) | 2019-06-19 | — | — | EP | disclosed |
| WO-2018033478-A1 | METHOD AND COMPOSITION FOR DETECTION OF PEPTIDE CYCLIZATION USING PROTEIN TAGS | F. HOFFMANN-LA ROCHE AG (CH) | 2018-02-22 | — | — | WO | disclosed |
| EP-3140310-A1 | SYNTHESIS OF BORONATE SALTS AND USES THEREOF | Rempex Pharmaceuticals, Inc. (US) | 2017-03-15 | — | — | EP | disclosed |
| WO-2015171430-A1 | SYNTHESIS OF BORONATE SALTS AND USES THEREOF | REMPEX PHARMACEUTICALS, INC. (US) | 2015-11-12 | — | — | WO | disclosed |
| EP-2861565-A2 | SUBSTITUTED MACROCYCLIC COMPOUNDS HAVING PROTEASOME INHIBITORY ACTIVITY | The Regents of The University of California (US) | 2015-04-22 | — | — | EP | disclosed |
| WO-2013188750-A2 | SUBSTITUTED MACROCYCLIC COMPOUNDS HAVING PROTEASOME INHIBITORY ACTIVITY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-12-19 | — | — | WO | disclosed |
| WO-2003091264-A2 | NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| EP-1283837-A1 | NEW THIOCHROMANE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | AstraZeneca AB (SE) | 2003-02-19 | — | — | EP | disclosed |
| WO-2001087879-A1 | NEW THIOCHROMANE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | ASTRAZENECA AB (SE) | 2001-11-22 | — | — | WO | disclosed |
| WO-2000029385-A1 | 1,4,5,6-TETRAHYDRO-PYRIDAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEURAMINIDASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2000-05-25 | — | — | WO | disclosed |
| EP-0938475-A1 | PIPERIDINE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 1999-09-01 | — | — | EP | disclosed |
| EP-0920410-A1 | PREPARATION OF CYCLOHEXENE CARBOXYLATE DERIVATIVES | GILEAD SCIENCES, INC. (US) | 1999-06-09 | — | — | EP | disclosed |
| WO-1999010365-A2 | 5',5'-LINKED OLIGOMERS HAVING ANTI-THROMBIN ACTIVITY | GILEAD SCIENCES, INC. (US) | 1999-03-04 | — | — | WO | disclosed |
| WO-1998017647-A1 | PIPERIDINE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 1998-04-30 | — | — | WO | disclosed |
| WO-1998007685-A1 | PREPARATION OF CYCLOHEXENE CARBOXYLATE DERIVATIVES | GILEAD SCIENCES, INC. (US) | 1998-02-26 | — | — | WO | disclosed |
| WO-1997049723-A1 | CATIONIC LIPIDS FOR DELIVERY OF NUCLEIC ACID TO CELLS | GILEAD SCIENCES, INC. (US) | 1997-12-31 | — | — | WO | disclosed |